CALL/ABBOTT LABORATORIES/120/0.1/21.06.24 Stock

Warrant

DE000GX8Z1M9

Real-time BOERSE MUENCHEN 02:26:57 2024-06-18 pm EDT
0.001 EUR -50.00% Intraday chart for CALL/ABBOTT LABORATORIES/120/0.1/21.06.24
Current month-71.43%
1 month-81.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-18 0.001 -50.00%
24-06-17 0.002 0.00%
24-06-14 0.002 -33.33%
24-06-13 0.003 -25.00%
24-06-12 0.004 -50.00%

Real-time BOERSE MUENCHEN

Last update June 18, 2024 at 02:26 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GX8Z1M
ISINDE000GX8Z1M9
Date issued 2022-09-06
Strike 120 $
Maturity 2024-06-21 (3 Days)
Parity 10 : 1
Emission price 0.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.33
Lowest since issue 0.001
Spread 0.02
Spread %95.24%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.19%
Consensus